Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00452790 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in India

StatusCompleted
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Secondary endpoint revised Primary endpoints revised (2)v16 Show all 2 changesShow less
    • Primary endpoints revised (2)

    See this version in full on ClinicalTrials.gov ↗

  2. Re-verified, no change to tracked fieldsv15
  3. Results first posted: Nov 15, 2010 Primary endpoints: 1 to 2 · Secondary endpoints expanded, about 22 wordsv14 Show all 3 changesShow less
    • Primary endpoints: 1 to 2
    • Secondary endpoints expanded, about 22 words

    See this version in full on ClinicalTrials.gov ↗

  4. Completion date: Dec 2009 to Feb 2010v13
  5. Primary completion date changed from estimate of Dec 2008 to Oct 2009 Study completion date changed from estimate of Dec 2008 to Dec 2009 · Trial status: Active, Not Recruiting to Completed · Enrollment target: estimated 354 to confirmed 708v12 Show all 4 changesShow less
    • Study completion date changed from estimate of Dec 2008 to Dec 2009
    • Trial status: Active, Not Recruiting to Completed
    • Enrollment target: estimated 354 to confirmed 708
Show 10 earlier versionsHide 10 earlier versions
  1. Re-verified, no change to tracked fieldsv11
  2. Study sites: 11 to 12v10
  3. Trial status: Recruiting to Active, Not Recruiting Study sites revised (11)v9 Show all 2 changesShow less
    • Study sites revised (11)

    See this version in full on ClinicalTrials.gov ↗

  4. Trial status: Active, Not Recruiting to Recruiting Study sites revised (11)v8 Show all 2 changesShow less
    • Study sites revised (11)

    See this version in full on ClinicalTrials.gov ↗

  5. Re-verified, no change to tracked fieldsv7
  6. Primary completion date: Dec 2008 Completion date: Sep 2007 to Dec 2008 · Interventions: 13-valent Pneumococcal Conjugate Vaccine (Biological) to 13-valent Pneumococcal Conjugate Vaccine (Biological), 7 valent pneumococcal conjugate vaccine (Biological) · Study arms: 0 to 2v6 Show all 4 changesShow less
    • Completion date: Sep 2007 to Dec 2008
    • Interventions: 13-valent Pneumococcal Conjugate Vaccine (Biological) to 13-valent Pneumococcal Conjugate Vaccine (Biological), 7 valent pneumococcal conjugate vaccine (Biological)
    • Study arms: 0 to 2
  7. Trial status: Recruiting to Active, Not Recruiting Study sites revised (11)v5 Show all 2 changesShow less
    • Study sites revised (11)

    See this version in full on ClinicalTrials.gov ↗

  8. Study sites: 3 to 11v4
  9. Enrollment target: 330 to 354v3
  10. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 3v2 Show all 2 changesShow less
    • Study sites: 0 to 3
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate vaccine (13vPnC) compared to Prevenar (7vPnC), when given concomitantly with routine paediatric vaccinations in India.
Trial Details
NCT Number NCT00452790
Lead Sponsor Wyeth is now a wholly owned subsidiary of Pfizer
Conditions Pneumococcal Infections
Enrollment 708 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov